Updated on 2026/05/22

写真a

 
NOGAMI Kazutaka
 
Organization
School of Medicine Department of Pediatrics Lecturer
Title
Lecturer
External link

Research Interests

  • Allergy

  • Pediatrics

Research Areas

  • Life Science / Embryonic medicine and pediatrics  / Allergy of Pediatrics

Research History

  • Sapporo Medical University   School of Medicine Department of pediatrics   Lecturer

    2026.4

    　 More details

    Country：Japan

    researchmap

Papers

  • SCCA2 as a biomarker reflecting patient-reported disease burden in children with mild atopic dermatitis under maintenance therapy. International journal

    Yasuaki Yasuda, Fumiko Iwai, Kana Hamada, Miyuki Hoshi-Funakawa, Kazutaka Nogami, Mayumi Matsunaga, Takafumi Takase, Mizuho Nagao, Shigeru Suga, Yoshinori Azuma, Masahiro Hirayama, Kenji Izuhara, Takao Fujisawa

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology   37 ( 2 )   e70298   2026.2

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    BACKGROUND: In mild atopic dermatitis (AD), evaluating disease activity during maintenance therapy is challenging due to subtle clinical signs. Serum squamous cell carcinoma antigen 2 (SCCA2) has been proposed as a sensitive biomarker, but its utility in assessing disease status specifically in mild AD remains unclear. OBJECTIVE: To assess the utility of serum SCCA2 in children with mild AD receiving maintenance therapy, focusing on its relationship with patient-reported outcomes. Serum thymus and activation-regulated chemokine (TARC), an established marker, was analyzed as a comparator. METHODS: Sixty-nine pediatric patients with mild AD were enrolled. Clinical severity was assessed by the Eczema Area and Severity Index (EASI; physician-rated) and the Patient-Oriented Eczema Measure (POEM; patient-reported). Baseline serum SCCA2 and TARC were measured. Associations were first examined using Spearman's rank correlation. Temporal associations between baseline SCCA2 and POEM at Days 3 and 7 were further evaluated using linear mixed-effects models, and complementary bootstrap resampling and Steiger's Z test were applied for correlation comparisons. RESULTS: Although all patients were classified as mild by EASI, POEM scores ranged widely, indicating discordance between physician- and patient-assessed severity. SCCA2, but not TARC, was significantly correlated with POEM scores at baseline. The correlation between baseline SCCA2 and POEM was strongest on Day 3 and attenuated by Day 7. Linear mixed-effects modeling confirmed a significant time-dependent association. CONCLUSION: SCCA2 reflects patient-experienced symptom burden more closely than physician-assessed severity in mild AD. Its short-term, time-dependent association with POEM suggests potential utility for identifying early or imminent symptom burden.

    DOI： 10.1111/pai.70298

    PubMed

    researchmap

  • Protein Z-type serpin identified as a novel barley allergen in pediatric FDEIA. International journal

    Taiga Kobayashi, Takuro Ito, Masashi Nakamura, Tomofumi Kawabe, Yukiko Hiraguchi, Reiko Tokuda, Mizuho Nagao, Takao Fujisawa, Kazutaka Nogami

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology   36 ( 12 )   e70267   2025.12

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1111/pai.70267

    PubMed

    researchmap

  • Efficacy and safety of systemic targeted therapies for atopic dermatitis in children: A systematic review and meta-analysis. International journal

    Norio Kawamoto, Hiroki Murai, Kazutaka Nogami, Takeshi Yamamoto, Tomonobu Kikkawa, Motoko Yasutomi-Sakai, Kiwako Yamamoto-Hanada, Masaki Futamura, Yukihiro Ohya

    Allergology international : official journal of the Japanese Society of Allergology   74 ( 3 )   424 - 434   2025.7

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    BACKGROUND: In recent years, several targeted therapeutic options have become available for the management of atopic dermatitis in children. In this systematic review and meta-analysis, we assessed the efficacy and safety of systemic targeted therapies for atopic dermatitis in children. METHODS: A systematic review of literature available in CENTRAL, MEDLINE, Embase, and ICHUSHI databases until January 7, 2023, was performed. Randomized controlled trials of systemic targeted therapies (biologics and small molecules) on children aged 18 years or younger with atopic dermatitis were included. The primary outcomes were the eczema area and severity index (EASI) and adverse events. Other efficacy and safety outcomes were also used for meta-analysis and risk of bias analysis. RESULTS: We included 10 studies reported in 11 articles involving three agents (dupilumab, abrocitinib, and upadacitinib) and 1760 children. Systemic targeted therapies significantly improved eczema severity with an EASI-75 response (risk ratio, 2.99; 95 % confidence interval [CI], 2.66-3.37). However, systemic targeted therapies were associated with treatment-emergent adverse events (risk difference, 0.05; 95 % CI, 0.01-0.09), particularly among small molecules in subgroup analysis, while no such trend was observed with biologics. Systemic targeted therapy also significantly improved other efficacy outcomes, and no significant association was found in the other safety outcomes. There was no risk of bias in any of the outcomes. CONCLUSIONS: Our findings indicate that systemic targeted therapies are effective and relatively safe for treating atopic dermatitis in children, although small molecules may pose a slightly higher risk of adverse events.

    DOI： 10.1016/j.alit.2024.11.007

    PubMed

    researchmap

  • Acute osteomyelitis/septic pulmonary embolism associated with familial infections caused by PVL-positive ST6562 MRSA-IVa, a presumptive variant of USA300 clone. International journal

    Nao Harada, Atsuo Togashi, Meiji Soe Aung, Jun Kunizaki, Kazutaka Nogami, Yoshinobu Nagaoka, Akira Ishii, Ima Kosukegawa, Wakiko Aisaka, Satoshi Nakamura, Tomohiro Wakabayashi, Takeshi Tsugawa, Nobumichi Kobayashi

    IJID regions   8   16 - 18   2023.9

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Panton-Valentine leukocidin (PVL)-positive methicillin-resistant Staphylococcus aureus (MRSA) occasionally causes severe invasive infections. A 10-year-old immunocompetent boy in Hokkaido, the northern main island of Japan, was admitted with acute osteomyelitis of the right ilium, complicated by septic thrombophlebitis of the right common iliac vein and septic pulmonary embolism. As MRSA was isolated from blood and sputum samples of the patient, linezolid and vancomycin were initially used for treatment, and later clindamycin was added based on PCR-positive results for PVL genes. During his hospitalization, the patient was complicated by abscesses around the right ilium and septic arthritis of the right hip, which required surgical drainage. Prior to his admission, his youngest sister had developed a right breast abscess, and another sister and his mother developed contagious impetigo and hordeolum, respectively, during his hospitalization. These infections in the patient and his family members were caused by an identical PVL-positive MRSA strain belonging to ST6562, a single-locus variant of ST8. Due to the genetically close characteristics, this ST6562 MRSA was considered a genetic variant of the USA300 CA-MRSA clone (ST8-MRSA-IVa) predominating in the United States. The ST6562 MRSA-IVa is suggested to have occurred in Japan, associated with potential spread of the USA300 clone.

    DOI： 10.1016/j.ijregi.2023.05.006

    PubMed

    researchmap

  • Sensitization to macadamia 7S globulin amino-terminus with clinical relevance in Japanese children with macadamia nut allergy. International journal

    Tomoaki Ando, Jiro Kitaura, Nobuyuki Maruyama, Masami Narita, Katsushi Miura, Yoshihiro Takasato, Kazutaka Nogami, Mizuho Nagao, Ko Okumura, Hideoki Ogawa, Hiroaki Onishi, Takashi Watanabe, Komei Ito, Takao Fujisawa, Motohiro Ebisawa, Toshiaki Kawakami, Kenji Matsumoto, Shunji Hasegawa, Yukihiro Ohya, Hiroki Yasudo

    Allergology international : official journal of the Japanese Society of Allergology   72 ( 2 )   351 - 353   2023.4

    　More details

  • House Dust Mite Subcutaneous Immunotherapy and Lung Function Trajectory in Children and Adolescents with Asthma. International journal

    Kazutaka Nogami, Mizuho Nagao, Takafumi Takase, Yasuaki Yasuda, Shingo Yamada, Mayumi Matsunaga, Miyuki Hoshi, Kana Hamada, Yu Kuwabara, Takeshi Tsugawa, Takao Fujisawa

    Children (Basel, Switzerland)   9 ( 4 )   2022.4

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Background: Allergen-specific immunotherapy is currently the only disease-modifying treatment for allergic asthma, and it has been shown to improve control of asthma while reducing both drug use and asthma exacerbations. However, its effects on lung function—especially its long-term effects—remain controversial. We aimed to identify factors associated with a possible beneficial effect of allergen-specific immunotherapy on lung function in asthma by retrospectively evaluating the long-term changes in lung function in children with asthma who received house dust mite subcutaneous immunotherapy (HDM-SCIT). Methods: We enrolled children with asthma who had undergone HDM-SCIT for more than 1 year. Clinical information and lung function measurements were retrieved from the electronic chart system. To characterize the trajectory of lung function change, we performed linear regression analysis to evaluate the maximal expiratory flow at 50% of the forced vital capacity during two periods: before and during HDM-SCIT. Slopes from a least-squares regression line for the two periods, i.e., S1 before HDM-SCIT and S2 during HDM-SCIT, were compared. The subjects were then classified into two groups: an improving group (Group I) defined as S2 − S1 > 0, and a declining group (Group D) defined as S2 − S1 < 0. The clinical factors at the start of HDM-SCIT were compared between the two groups. Results: A total of 16 patients were analyzed. Eight patients were classified into each of Group I and Group D. The mean ages were 10.5 and 11.8 years, and the mean treatment periods were 4.1 and 3.9 years. Group I had a significantly lower blood eosinophil count and a significantly higher HDM-specific IgE level than Group D. Logistic regression showed a strong relationship between those two markers and the lung function trajectory. Conclusion: Control of the blood eosinophil count in highly HDM-sensitized patients may increase the beneficial effect of HDM-SCIT on lung function.

    DOI： 10.3390/children9040487

    PubMed

    researchmap

  • Development of allergic rhinitis in early life: A prospective cohort study in high-risk infants. International journal

    Sawako Masuda, Mizuho Nagao, Satoko Usui, Kazutaka Nogami, Yuji Tohda, Takao Fujisawa

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology   33 ( 2 )   e13733   2022.2

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    BACKGROUND: Allergic rhinitis (AR) is the most common allergic disease in children. The development process of AR in early childhood, however, is not well understood. We prospectively investigated the process in regard to not only the nasal symptoms and sensitization but also the nasal cytology, in relation to recurrent wheeze in a high-risk cohort. METHODS: Infants under 2 years of age with atopic dermatitis (AD) and/or food allergy (FA) symptoms were recruited and followed prospectively for 2 years. The phenotype of perennial AR was classified based on the presence/absence of (1) persistent nasal symptoms, (2) nasal eosinophils, and (3) HDM sensitization, the most common allergen for perennial AR in Japan. AR-like phenotypes were defined as positive for at least two of those three categories. High-risk recurrent wheezer was diagnosed based on the Japanese guidelines and Global Initiative for Asthma. Cox proportional hazards regression analyses for high-risk recurrent wheeze and the AR-like phenotype, adjusting for known covariate risk factors for asthma. RESULTS: A total of 299 children were enrolled, and 237 subjects (78%) completed the 2-year observation. The prevalence of eosinophilia in nasal secretions increased from 18.5% to 69.9%, while HDM-specific IgE ≥ 0.35 kUA /L increased from 30.6% to 74.8%. AR-like phenotypes increased from 18.4% to 65.0%. The AR-like phenotype at 2 years was associated with development of high-risk recurrent wheezer (HR 2.062; 95% CI 1.005-4.796). CONCLUSIONS: The prevalence of an HDM-related AR-like phenotype was markedly increased during infancy in infants with AD/FA and was associated with high-risk recurrent wheezer.

    DOI： 10.1111/pai.13733

    PubMed

    researchmap

  • Factors associated with outcome of egg allergy 1 year after oral food challenge: A good baseline quality of life may be beneficial. International journal

    Kana Hamada, Mizuho Nagao, Ryo Imakiire, Kanae Furuya, Yumi Mizuno, Yasunori Sato, Mayumi Matsunaga, Shingo Yamada, Kazutaka Nogami, Miyuki Hoshi, Taiga Kobori, Keigo Kainuma, Kazumoto Iijima, Takao Fujisawa

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology   32 ( 7 )   1490 - 1496   2021.10

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    BACKGROUND: Safely liberalizing the diet to include an allergenic food may accelerate resolution of food allergy. The outcome of liberalization, however, varies among patients. METHODS: We conducted a prospective observational study to identify factors associated with outcome for egg allergy 1 year after oral food challenge (OFC). We enrolled children <72 months old who had egg allergy and underwent OFC for determination of the safe intake quantity of egg allergen. Each child's baseline clinical background was recorded. Caregivers used the Food Allergy Quality of Life Questionnaire-Parent Form (FAQLQ-PF) to assess their children's QoL. Dietary advice based on the OFC result was provided to support safe egg consumption. At 1 year after OFC, the quantity of egg each child safely consumed in daily life was surveyed. We classified the outcome as Successful (Group S) if the quantity increased during the 1 year, or as Unsuccessful (Group U) if it did not. Factors associated with the outcome were investigated by multivariate logistic regression analysis. RESULTS: A total of 93 children were enrolled, and after 1 year, 57 finished in Group S and 36 in Group U. The mean FAQLQ-PF score at baseline was significantly lower (ie, a better QoL) in Group S than in Group U. Multivariate logistic regression analysis identified a good QoL and absence of comorbid asthma or atopic dermatitis as factors predicting a favorable outcome. CONCLUSION: QoL may affect food allergy outcome. Intervention focusing on the QoL may promote outgrowing of food allergies.

    DOI： 10.1111/pai.13534

    PubMed

    researchmap

  • Three cases of severe adolescent asthma treated with mepolizumab: lung function trajectories. International journal

    Miyuki Hoshi, Mayumi Matsunaga, Kazutaka Nogami, Kana Hamada, Taiga Kobori, Keigo Kainuma, Mizuho Nagao, Takao Fujisawa

    Asia Pacific allergy   10 ( 2 )   e13   2020.4

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Real-world experience with mepolizumab for pediatric asthma is still limited. We report 3 patients who were treated with mepolizumab for severe adolescent asthma. Two patients, a 12-year-old boy and a 14-year-old girl, responded well to mepolizumab and showed apparent improvement in lung function from a downward trend over time before treatment. The third patient, a 16-year-old boy, whose treatment was switched from omalizumab to mepolizumab, did not have satisfactory response. The 2 successful cases had eosinophil counts of 440 and 371/μL and multiple comorbid allergic diseases including food allergies. The clinical benefit to them included elimination of both exacerbation and exercise-induced asthma. Interestingly, the boy's food-induced gastrointestinal symptoms disappeared following start of mepolizumab treatment.

    DOI： 10.5415/apallergy.2020.10.e13

    PubMed

    researchmap

  • Adrenocortical carcinoma characterized by gynecomastia: A case report.

    Takako Takeuchi, Yuko Yoto, Akira Ishii, Takeshi Tsugawa, Masaki Yamamoto, Tsukasa Hori, Hotaka Kamasaki, Kazutaka Nogami, Takanori Oda, Akihiro Nui, Sachiko Kimura, Takuya Yamagishi, Keiko Homma, Tomonobu Hasegawa, Maki Fukami, Yoko Watanabe, Hidehiko Sasamoto, Hiroyuki Tsutsumi

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology   27 ( 1 )   9 - 18   2018

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    We present a 4-yr-old boy with adrenocortical carcinoma (ACC), diagnosed due to the appearance of gynecomastia as the presenting symptom. Six months prior to admission, an acute growth spurt along with the development of bilateral breast swelling was observed. He did not present any features of virilization, including enlargement of the testes, increase in testis volume, and penis size. Laboratory investigations showed gonadotropin-independent hypergonadism, with low LH/ FSH levels and elevated estradiol/testosterone levels. Abdominal computed tomography revealed a large heterogeneous mass adjacent to the right kidney and below the liver. Pathological investigations of the biopsy specimen demonstrated that the tumor was an ACC. Pre- and post-operative combination chemotherapy with mitotane was administered and surgical resection was carried out. Post-surgery, the elevated estradiol/testosterone concentrations reverted to within the reference range. Urinary steroid profile and tissue concentration analysis of estradiol and testosterone indicated the presence of estrogen in the ACC tissue. An investigation for TP53 gene aberrations revealed the presence of a germline point mutation in exon 4 (c.215C>G (p.Pro72Arg)). In ACC, the most common symptom is virilization, and feminization, characterized by gynecomastia, is very rare. However, a diagnostic possibility of ACC should be considered when we encounter patients who have developed gynecomastia without the influence of causative factors such as obesity or puberty, and do not present with the typical signs of virilization.

    DOI： 10.1297/cpe.27.9

    PubMed

    researchmap

▼display all

MISC

▼display all